Neumora Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. 

CEO
Paul L. Berns
CEOPaul L. Berns
Employees
110
Employees110
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2019
Founded2019
Employees
110
Employees110

NMRA Key Statistics

Market cap
122.12M
Market cap122.12M
Price-Earnings ratio
-0.50
Price-Earnings ratio-0.50
Dividend yield
—
Dividend yield—
Average volume
1.03M
Average volume1.03M
High today
$0.7647
High today$0.7647
Low today
$0.7335
Low today$0.7335
Open price
$0.76
Open price$0.76
Volume
910.03K
Volume910.03K
52 Week high
$17.19
52 Week high$17.19
52 Week low
$0.6211
52 Week low$0.6211

Analyst ratings

56%

of 9 ratings
Buy
33.3%
Hold
55.6%
Sell
11.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.